More articles from MTA II: Endocrinology/Neuroendocrine Tumor Posters

You have access
SPECT/CT alters management by revealing hyperemia of inflammation as the cause of false-positive I-131 whole-body scans in post-thyroidectomy thyroid cancer patients
Yana Garger, Matthew Winfeld, Kent Friedman and Manfred Blum

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 2080;
You have access
Comparison of I-123 MIBG scintigraphy with somatostatin receptor scintigraphy using Tc-99m HYNIC TATE in neuroblastoma patients
Lebriz Uslu, Levent Kabasakal, Meltem Ocak, Gulen Tuysuz, Tiraje Celkan, Hilmi Apak and Bedii Kanmaz

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 2103;
You have access
Analysis of common factors influencing the 131I therapeutic efficacy on differentiated thyroid cancer
Zairong Gao and Kunwei Cui

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 2068;
You have access
Glucagon-like peptide-1 receptor SPECT/CT for the preoperative localization of benign insulinomas
Damian Wild, Emanuel Christ, Susanne Ederer, Martin Behe, Helmut Maecke, Wolfgang Weber, Jamshed Bomanji, Martyn Caplin, Jean Claude Reubi and Flavio Forrer

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 2072;
You have access
I-131 therapy with retinoic acid in patients with radioiodine-refractory papillary thyroid carcinoma
Kyung Sook Jo, Su Jin Lee, Hee Sung Song, Seok-Ho Yoon, Young-Sil An and Joon-Kee Yoon

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 2065;
You have access
Is empiric iodine therapy effective in patients with normal PET scans and elevated thyroglobulin levels?
Erin Grady, Timothy Manzone, Hung Dam, Loral Farrell and Maria Sumner

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 2055;
You have access
Fate of benign nodules co-existing in Graves' hyperthyroidism following radioiodine therapy. Short term results
Kunihiro Nakada, Mutsuo Beniko, Ichiro Sakuma, Tsunenori Mizukoshi and Masayuki Sakurai

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 2078;
You have access
Distinguishing lymph node metastases from thyroid remnants in differentiated thyroid cancer patients using kinetic parameters estimated from I-124-PET/CT images
James Nagarajah, Michael Kreissl, Andreas Bockisch and Walter Jentzen

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 2087;
You have access
Evaluation of 68Ga-DOTA-TATE and 68Ga-DOTA-NOC PET/CT in patients with differentiated thyroid cancer
Emre Demirci, Levent Kabasakal, Meltem Ocak, Aslan Aygun, Metin Halac and Bedii Kanmaz

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 2095;
You have access
Comparison of ⁶⁸Ga-DOTATOC PET acquired by an integrated hybrid PET/MR and a PET/CT scanner in patients with neuroendocrine tumors
Florian Gaertner, Michael Souvatzoglou, Klemens Scheidhauer, Ambros Beer, Florian Brohl, Sebastian Fürst, Sibylle Ziegler and Markus Schwaiger

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 2075;

Main menu

User menu

Search

More articles from MTA II: Endocrinology/Neuroendocrine Tumor Posters

Pages